Adoptive Cell Therapy in Solid Tumors: How Can We Mitigate Risk and Optimize Rewards?
Although immune checkpoint inhibitor therapy has revolutionized the treatment of solid tumors, immunologically “cold” tumors remain difficult to treat. Adoptive cell therapy—particularly, tumor-infiltrating lymphocyte therapy—shows promise in this space.